Structured telephone support or telemonitoring programs for patients with chronic heart failure by Inglis, Sally C. et al.
Structured telephone support or telemonitoring programs for
patients with chronic heart failure (Protocol)
Inglis SC, Clark RA, Cleland JGF, McAlister F, Stewart S
This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration and published in The Cochrane
Library 2008, Issue 3
http://www.thecochranelibrary.com
Structured telephone support or telemonitoring programs for patients with chronic heart failure (Protocol)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iStructured telephone support or telemonitoring programs for patients with chronic heart failure (Protocol)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Protocol]
Structured telephone support or telemonitoring programs for
patients with chronic heart failure
Sally C Inglis1, Robyn A Clark2, John GF Cleland3, Finlay McAlister4, Simon Stewart5
1Schools of Medicine and Nursing , University of Queensland, Brisbane, Australia. 2Faculty of Health Sciences, University of South
Australia, Adelaide, Australia. 3Academic Unit of Cardiology, Castle Hill Hospital, East Yorkshire, UK. 4Division of General Internal
Medicine, University of Alberta, Edmonton, Canada. 5Preventative Cardiology, Baker Heart Research Institute, Prahan, Australia
Contact address: Sally C Inglis, Schools of Medicine and Nursing , University of Queensland, Brisbane, Australia.
scinglis2@hotmail.com.
Editorial group: Cochrane Heart Group.
Publication status and date: New, published in Issue 3, 2008.
Citation: Inglis SC, Clark RA, Cleland JGF, McAlister F, Stewart S. Structured telephone support or telemonitoring pro-
grams for patients with chronic heart failure. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD007228. DOI:
10.1002/14651858.CD007228.
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objective of this study is to update the review previously completed by Clark 2007b and assess systematically the effects of
telemonitoring and/or structured telephone support programmes on:
1. all cause mortality, CHF-related admission to hospital, all-cause readmissions to hospital and length of stay and;
2. quality of life, healthcare cost savings in patients with CHF.
The cost of the intervention and acceptability of the intervention to patients will also be examined.
B A C K G R O U N D
Description of the condition
Chronic heart failure (CHF) is a complex, debilitating syndrome
which is the consequence of structural abnormality or cardiac dys-
function that impairs the ability of the ventricle to fill with, or eject
blood. As a result typical symptoms such as dyspnoea and fatigue
occur at rest or with physical effort. CHF often results from dam-
age to the myocardium for which the aetiology differs according
to the population studied. In high income nations CHF is often
the end-product of underlying coronary heart disease. In low to
medium income nations the syndrome is often the result of long-
standing hypertension, cardiomyopathy or rheumatic heart dis-
ease (Sliwa 2005). This trend is changing, with the incidence and
prevalence of cardiovascular disease increasing in low to medium
income nations (Yusuf 2001). CHF exerts a significant burden on
healthcare systems, with the majority of its economic burden at-
tributable to repeated and lengthy admissions to hospital (Stewart
2002). As the prevalence of CHF increases with the ageing of pop-
ulations internationally, this situation will deteriorate unless new
management strategies are developed (Cleland 2000).
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Description of the intervention
The effectiveness of multidisciplinary non-pharmacological ap-
proaches to manage patients with CHF has been proven by meta-
analyses, such as that conducted by Taylor 2005 and Cleland 2000
and specialist CHF disease management programmes are now rec-
ommended in best practice guidelines (Hunt 2005; Krum 2006;
Swedburg 2005).
To date, trials of specialist, multidisciplinary CHF management
programmes have testedmultifaceted approaches (home/clinic vis-
its, telephone support). As a consequence it has been difficult to
identify the incremental benefits of the components of each in-
tervention (McAlister 2004). Nevertheless, it is clear that within
most populations access to these programmes is limited as a result
of barriers related to funding or geography (Clark 2007a; Jaarsma
2006). To meet the needs of CHF populations who are distal to
traditional home or clinic-based CHF disease management pro-
grammes, alternativemodels of care have been proposed and tested
(Clark 2007a). These alternativemodels typically involve informa-
tion communication technology (ICT) and may include telemon-
itoring (transfer of physiological data via digital cable e.g. electro-
cardiograph (ECG), blood pressure (BP), weight, pulse oximetry
(SPO2) respiratory rate and medicine administration) or struc-
tured computer-assisted education and monitoring delivered via
standard telephone or videoconferencing (Clark 2007b).
These remote monitoring programmes may allow patients who
can not or do not wish to be visited at home, or those that are
unable to attend a clinic or do not have local access to traditional
CHF management programmes, to receive the best practice for
non-pharmacological management of CHF.
It should be noted that in the context of this review “remote mon-
itoring” will be defined as monitoring CHF patients outside of a
CHF specialist centre of care and not remote in the geographical
sense, although these patients are often one in the same group.
In all studies of structured telephone support, having access to a
touch-tone telephonewas an essential inclusion criteria. In the case
of telemonitoring the ICT equipment and monitoring devices are
provided by the project. Patients from socio-economically disad-
vantaged groups would have been excluded if they did not have
access to a basic telephone in their place of residence.
Why it is important to do this review
In this era of rapidly advancing technology and wider commu-
nity access and adaptation to ICT, new trials of remote mon-
itoring interventions are continually being commissioned and
published. Previous systematic reviews and meta-analyses (Clark
2007b; Louis 2003; McAlister 2004) have examined the bene-
fits of telemonitoring and/or structured telephone support within
CHF disease management programmes on mortality and hospi-
talisation, however to date only a few trials have been included in
these reviews.
By far the largest systematic review and meta-analysis to date
of those which have examined these programmes (Clark 2007b;
Louis 2003; McAlister 2004) is that by Clark 2007b. Clark re-
ported benefits on the rate of admission to hospital for CHF and
on all-cause mortality in 14 trials. The reviews of Louis 2003 and
McAlister 2004 were published before a significant number of tri-
als had been published to demonstrate effect.
Previous findings by Clark 2007b suggest that remote strategies
such as telemonitoring and/or structured telephone support might
have an important role as a part of a strategy for the delivery of
effective healthcare for patients with CHF. They may also provide
a means for keeping patients under close supervision, which could
reduce the rate of admission, length of stay and subsequent cost
to the healthcare system.
At the time of Clark’s review (Clark 2007b) only 14 trials of remote
monitoring were available and suitable for inclusion. The authors
of this review are aware of several large trials of remote monitoring
(in particular those of Mortara 2004 and Scalvini 2004) for which
final results will soon be published. Considering the interest of
healthcare providers to provide healthcare via thismode to patients
withCHF it is pertinent to perform themost up-to-date evaluation
of these interventions.
O B J E C T I V E S
The objective of this study is to update the review previously com-
pleted by Clark 2007b and assess systematically the effects of tele-
monitoring and/or structured telephone support programmes on:
1. all cause mortality, CHF-related admission to hospital, all-
cause readmissions to hospital and length of stay and;
2. quality of life, healthcare cost savings in patients with CHF.
The cost of the intervention and acceptability of the intervention
to patients will also be examined.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials or controlled trials (that is studies in
which a contemporaneous comparison group is identified but in
which random allocation to intervention or comparison groupwas
not performed) comparing CHFmanagement delivered via struc-
tured telephone support and/or telemonitoring with usual post-
discharge care in patients with CHF living within the community.
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Studies will be included in the analyses regardless of whether they
are single-blind, double-blind or not blinded.
Types of participants
Adult (aged 18+ years) of either sex, any age or ethnic group with
definitive diagnosis of CHF discharged from an acute care setting
(including emergency departments and one-day-stay procedures)
to home (including a relative’s home but excluding nursing homes
or convalescence homes). Studies dealing generally with cardiac
disorders but not specifically denoting CHF will be excluded.
Types of interventions
Structured telephone support and/or telemonitoring interventions
need to be structured as opposed to offering telephone follow-up
on an “as needed” basis. They must be initiated by a healthcare
professional (medical, nursing, social work, pharmacist) and deliv-
ered to patients with CHF living in the community as the only af-
tercare intervention, without home visits or more than usual clinic
follow-up.They must be performed at least once within the first
28 days following discharge from hospital, they must be targeted
towards the patient, and intended to address the patients concerns
and problems not those of caregivers.
Usual care will consist of standard post-discharge care without reg-
ular attendance at a clinic-based CHF disease management pro-
gramme or any visits at home by a specialised CHF healthcare
professional.
Types of outcome measures
Primary outcomes
• All-cause mortality (total number of deaths at the end of
study follow-up in each arm of the study).
Secondary outcomes
• All-cause hospitalisation rate (calculated as the proportion
of patients readmitted to hospital at least once during the period
of follow-up).
• Chronic heart failure-related hospitalisation rate (calculated
as the proportion of patients readmitted to hospital at least once
during the period of follow-up due to chronic heart failure).
• Length of stay (total number of days in hospital
accumulated by each study group)
• Health-related quality of life (difference between mean total
score on validated measures such as Minnesota Living with Heart
Failure Questionnaire between baseline and at study conclusion
for the intervention and control groups).
• Cost of the intervention, costs savings (reported cost of the
intervention; reported difference in the cost of medical care
during the course of the study between the intervention and
control groups).
• Acceptability of the intervention to patients (difference
between acceptability/satisfaction scores on a Likert scale at
study conclusion between the intervention and control groups).
Search methods for identification of studies
Electronic searches
The following databases will be searched, from 7 May 2006 for-
wards to update the search performed for from the previous review
(Clark 2007b): Cochrane Central Register of Controlled Trials
(CENTRAL) on The Cochrane Library; MEDLINE; EMBASE;
CINAHL;AMED; ScienceCitation IndexExpanded;DARE;Na-
tional Research Register. No date limits will be applied to the
searches of the following databases; IEEEXplore; OAIster; Google
Scholar; Informit; Vivisimo; Australian Digital Theses Program
and Proquest Digital Dissertations.
Language restrictions will not apply.
Details of the strategies for searching these electronic databases are
in Appendix 1.
Searching other resources
Bibliographies of identified studies and published systematic re-
views relevant to this topic area will be hand searched. National
and international experts in the field will be contacted to identify
published and/or unpublished trials.
Data collection and analysis
Selection of studies
Two investigators will independently review the results of each
search according to exclusion and inclusion criteria. Studies will
be excluded if there are additional home or clinic visits (more than
usual care) offered to patients in the interventionor control groups.
A third reviewer will adjudicate in the instance of indecision by
the first two reviewers.
Data extraction and management
Two reviewers will abstract the data from the included studies in
a blinded manner and all extracted data will be checked by a third
reviewer.
3Structured telephone support or telemonitoring programs for patients with chronic heart failure (Protocol)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Assessment of risk of bias in included studies
In consideration of Cochrane methodology (Higgins 2006) study
quality will be assessed independently by two reviewers.
The study quality characteristics will be rated as (1) unclear or not
stated; (2) inadequate; (3) adequate with examples from the text
to support this classification.
Adequacy and inadequacy of each of the study quality parameters
will be defined as follows.
Inclusion criteria of the included participants
The definition and confirmation of diagnosis of CHF.
• Adequate - LVEF< 40%, a diagnosis of CHF (systolic or
preserved) recorded
• Inadequate - LVEF >40% or ventricular dysfunction not
classified
Generation of the randomisation sequence
• Adequate - random permuted blocks, random computer
generated, sealed assignment, sequentially numbered sealed
opaque envelopes.
• Inadequate - case record numbers, date of birth or days of
the week.
Allocation concealment
• Adequate - allocation to each group performed adequately
and group assignment revealed after provision of consent.
• Inadequate - group assignment revealed prior to subject
consent, non-opaque sealed envelopes, case record numbers, date
of birth or day of the week.
Baseline comparability of the groups
• Adequate - the baseline characteristics of each study group
(in particular age, NYHA Class and/or LVEF) is clearly outlined
and any differences identified are accounted for.
• Inadequate - baseline characteristics (in particular age,
NYHA Class and/or LVEF) of each study group are not outlined.
Blinding
Focused on outcomes assessors and data analysts, it is not con-
sidered plausible that patients could be blinded to these types of
interventions).
• Adequate - independent outcome assessors and data
analysts who are blinded to which group the patient belongs to.
• Inadequate - outcomes assessed and data analysed by those
involved in the intervention, or those who are aware of group
membership.
Completeness of follow up
• Adequate - proportion and characteristics of those
participants lost to follow up clearly reported for each group and
outcome. A clear outline is provided as to how losses of
participants were handled.
• Inadequate - proportion and characteristics of those
completing and not completing the study according to group
and outcome not reported. No statement regarding how losses to
follow up were accounted for in the study analysis.
Statistical power
• Adequate - a power calculation was performed and
reported. The study was adequately powered to detect differences
in outcomes.
• Inadequate - a power calculation was not performed. A
power calculation was performed and reported but the study was
not adequately powered to detect differences in outcomes. A
power calculation was performed but not reported, the study
states it was adequately powered to detect differences in
outcomes.
Risk of bias (selection, performance, detection and attrition)
Risk of bias will be identified for each included study and tabulated
according to the following headings.
• Type of bias.
• Definition of the type of bias relevant to these types of
studies and interventions.
• Example from text suggesting a possible source of bias.
• Comment on how this potential source of bias my have
influence the study outcomes.
• Overall judgement on the importance of this identified
potential source of bias on study quality and validity.
Measures of treatment effect
Risk ratios and 95% confidence intervals will be calculated for all-
cause mortality, all-cause and CHF-related hospitalisation rates.
All analyses will be performed according to intention-to-treat prin-
ciples, that is, all patients and their outcomes will be analysed in
the groups to which theywere allocated, regardless of whether they
received the treatment.
Should there be sufficient reporting of continuous outcomes such
as quality of life measured byMinnesota Living with Heart Failure
Questionnaire these will be pooled and analysed accordingly. If
there is infrequent or inconsistent reporting of these outcomes
these will be tabulated and described.
Assessment of heterogeneity
Statistical heterogeneity in each outcome of interest will be exam-
ined using Cochran’s Q test and I2 statistic.
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Data synthesis
Owing to expected differences in patient populations, programme
characteristics, and length of follow-up, a Der Simonian and Laird
random effects model will be used to perform the meta-analysis.
Sensitivity analysis
A sensitivity analysis will be performed according to severity of
CHF (i.e. NYHA Class I and II versus III and IV) of included
participants. Another sensitivity analysis will examine the inclu-
sion criteria of the studies, comparing those which reported an
adequate classification of CHF diagnosis (i.e. left ventricular ejec-
tion fraction (LVEF)) relative to those which only stated “patients
with CHF”.
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A P P E N D I C E S
Appendix 1. Search strategies
MEDLINE (Ovid Web version)
1 exp Heart Failure/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telemedicine/
6 exp Telecommunications/
7 Case Management/
8 exp Comprehensive Health Care/
9 disease management/
10 telemed$.tw.
11 telecare$.tw.
12 telecardiol$.tw.
13 telemonitor$.tw.
14 teleconsult$.tw.
15 teleconferenc$.tw.
16 telecommunicat$.tw.
17 telephon$.tw.
18 telehealth$.tw.
19 telemetry.tw.
20 (remote$ adj3 consult$).tw.
21 tele-med$.tw.
22 tele-consult$.tw.
23 tele-conferenc$.tw.
24 tele-health$.tw.
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25 Home Care Services/
26 Home Care Services, Hospital-Based/
27 disease management.tw.
28 Nurse Clinicians/
29 Nurse Practitioners/
30 nurse led.tw.
31 Monitoring, Ambulatory/
32 telehome.tw.
33 tele-home.tw.
34 phone$.tw.
35 Clinical Protocols/
36 Patient Care Planning/
37 or/5-36
38 37 and 4
39 randomized controlled trial.pt.
40 controlled clinical trial.pt.
41 Randomized controlled trials/
42 random allocation/
43 double blind method/
44 single-blind method/
45 or/39-44
46 exp animal/ not humans/
47 45 not 46
48 clinical trial.pt.
49 exp Clinical Trials as Topic/
50 (clin$ adj25 trial$).ti,ab.
51 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab.
52 placebos/
53 placebo$.ti,ab.
54 random$.ti,ab.
55 research design/
56 or/48-55
57 56 not 46
58 57 not 47
59 comparative study.pt.
60 exp evaluation studies/
61 follow up studies/
62 prospective studies/
63 (control$ or prospectiv$ or volunteer$).ti,ab.
64 or/59-63
65 64 not 46
66 65 not (47 or 58)
67 47 or 58 or 66
68 38 and 67
69 [limit by date]
CINHAL (Ovid Web version)
1. (congestive adj heart adj failure).mp. [mp=title, subject heading word, abstract, instrumentation]
2. (heart adj failure).mp. [mp=title, subject heading word, abstract, instrumentation]
3. (cardiac adj failure).mp. [mp=title, subject heading word, abstract, instrumentation]
4. 1 or 2 or 3
5. (patient adj care adj management).mp. [mp=title, subject heading word, abstract, instrumentation]
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6. (patient adj care adj management).mp. [mp=title, subject heading word, abstract, instrumentation]
7. (home adj care adj services).mp. [mp=title, subject heading word, abstract, instrumentation]
8. (patient adj care).mp. [mp=title, subject heading word, abstract, instrumentation]
9. (manag$ adj care).mp. [mp=title, subject heading word, abstract, instrumentation]
10. (home adj intervention).mp. [mp=title, subject heading word, abstract, instrumentation]
11. (home adj care).mp. [mp=title, subject heading word, abstract, instrumentation]
12. (secondary adj prevent#).mp. [mp=title, subject heading word, abstract, instrumentation]
13. homecare.mp. [mp=title, subject heading word, abstract, instrumentation]
14. rehabilitat#.mp. [mp=title, subject heading word, abstract, instrumentation]
15. nurs?.mp. [mp=title, subject heading word, abstract, instrumentation]
16. multidisciplin?.mp. [mp=title, subject heading word, abstract, instrumentation]
17. discharge near plan?.mp. [mp=title, subject heading word, abstract, instrumentation]
18. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
19. 4 and 18
20. exp telephone/
21. exp telecommunication/
22. exp phone/
23. tele, communication?.mp. [mp=title, subject heading word, abstract, instrumentation]
24. tele? communication.mp. [mp=title, subject heading word, abstract, instrumentation]
25. telemedicine.mp. [mp=title, subject heading word, abstract, instrumentation]
26. phone.mp. [mp=title, subject heading word, abstract, instrumentation]
27. phonecall$.mp. [mp=title, subject heading word, abstract, instrumentation]
28. telephon?.mp. [mp=title, subject heading word, abstract, instrumentation]
29. phon?.mp. [mp=title, subject heading word, abstract, instrumentation]
30. call? back.mp. [mp=title, subject heading word, abstract, instrumentation]
31. electronic communication.mp. [mp=title, subject heading word, abstract, instrumentation]
32. tele?health.mp. [mp=title, subject heading word, abstract, instrumentation]
33. exp telenursing/
34. exp telehealth/
35. tele?nurs?.mp. [mp=title, subject heading word, abstract, instrumentation]
36. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35
37. 19 and 36
38. Experimental Studies/
39. exp Clinical trials/
40. ((control$ or clinic$ or prospectiv$) adj5 (trial$ or study or studies)).tw.
41. ((allocat$ or assign$ or divid$) adj5 (condition$ or experiment$ or treatment$ or control$ or group$)).tw.
42. ((singl$ or doubl$) adj (blind$ or mask$)).tw.
43. cross?over$.tw.
44. placebo$.tw.
45. exp Clinical research/
46. Comparative studies/
47. exp Evaluation research/
48. exp “control (research)”/
49. Random assignment/
50. exp Prospective studies/
51. exp Evaluation research/
52. random$.tw.
53. RCT.tw.
54. (compar$ adj5 (trial$ or study$ or studies)).tw.
55. or/35-51
EMBASE (Ovid)
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1 exp Heart Failure/
2 heart failure.tw.
3 cardiac failure.tw.
4 or/1-3
5 exp Telemedicine/
6 exp Telecommunications/
7 Case Management/
8 disease management/
9 telemed$.tw.
10 telecare$.tw.
11 telecardiol$.tw.
12 telemonitor$.tw.
13 teleconsult$.tw.
14 teleconferenc$.tw.
15 telecommunicat$.tw.
16 telephon$.tw
17 telehealth$.tw.
18 telemetry.tw.
19 (remote$ adj3 consult$).tw.
20 tele-med$.tw.
21 tele-consult$.tw.
22 tele-conferenc$.tw.
23 tele-health$.tw.
24 Home Care/
25 Home Monitoring/
26 disease management.tw.
27 Nurse Practitioners/
28 nurse led.tw.
29 Ambulatory Monitoring/
30 telehome.tw.
31 tele-home.tw.
32 phone$.tw.
33 Patient Care Planning/
34 or/5-33
35 34 and 4
36 controlled clinical trial/
37 random$.tw.
38 randomized controlled trial/
39 follow-up.tw.
40 double blind procedure/
41 placebo$.tw.
42 placebo/
43 factorial$.ti,ab.
44 (crossover$ or cross-over$).ti,ab.
45 (double$ adj blind$).ti,ab.
46 (singl$ adj blind$).ti,ab.
47 assign$.ti,ab.
48 allocat$.ti,ab.
49 volunteer$.ti,ab.
50 Crossover Procedure/
51 Single Blind Procedure/
52 or/36-51
53 35 and 52
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54 [limit by date]
CENTRAL on The Cochrane Library
#1 MeSH descriptor Heart Failure, Congestive explode all trees
#2 heart next failure
#3 cardiac next failure
#4 (#1 or #2 or #3)
#5 MeSH descriptor telemedicine explode all trees
#6 MeSH descriptor telecommunications explode all trees
#7 MeSH descriptor case management this term only
#8 MeSH descriptor comprehensive health care explode all trees
#9 MeSH descriptor disease management this term only
#10 MeSH descriptor home care services this term only
#11 MeSH descriptor Home Care Services, Hospital-Based this term only
#12 MeSH descriptor Nurse Clinicians this term only
#13 MeSH descriptor nurse practitioners this term only
#14 MeSH descriptor monitoring, ambulatory this term only
#15 MeSH descriptor clinical protocols this term only
#16 MeSH descriptor patient care planning this term only
#17 tele*
#18 (remote near/3 consult* )
#19 disease next management
#20 nurse next led
#21 phone*
#22 (manage* near/3 program* )
#23 (nurse* near/3 manage* )
#24 case next management
#25 (home near/3 service* )
#26 nurse next practitioner*
#27 nurse next clinician*
#28 care next plan*
#29 (#5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13)
#30 (#14 or #15 or #16 or #17 or #18 or #19 or #20 or #21)
#31 (#22 or #23 or #24 or #25 or #26 or #27 or #28)
#32 (#29 or #30 or #31)
#33 (#4 and #32)
H I S T O R Y
Protocol first published: Issue 3, 2008
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